Vivani Medical Eyes August Human Trial for Semaglutide Implant After Novo Nordisk Deal
Key Points Interested in Vivani Medical, Inc.? Here are five stocks we like better. Vivani Medical plans to…
Novo Nordisk signs pact to assess semaglutide implant
Novo Nordisk, the owner of the Ozempic and Wegovy GLP-1 drugs, has announced a deal to work with…
Novo Nordisk (CPSE:NOVO B) Teams Up With Vivani To Test A Semaglutide Implant
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million…
Novo Nordisk signs pact with Vivani for long-lasting semaglutide implant
Novo Nordisk has taken an interest in a weight-loss implant developed by Californian medtech Vivani Medical, reflecting a…
Vivani Medical Enters into Agreement with Novo Nordisk to
ALAMEDA, Calif., July 07, 2026 (GLOBE NEWSWIRE) — Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), an…
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
Novo Nordisk will conduct a non-exclusive internal evaluation of semaglutide implants prepared by Vivani ALAMEDA, Calif., July 07,…